Evgeniy N Ostroumov¹*, Elena D Kotina², Ekaterina B Leonova³, Irina M Kuzmina⁴ and Mstislav V Parkhomenko⁵

¹Professor, Senior Lecturer of the Educational Center, N.V. Sklifosovsky Research Institute for Emergency Medicine, Ostroumov, Russia
²Professor, Head, Department for Diagnostics of Functional Systems, St. Petersburg State University, Russia
³Postgraduate, St. Petersburg State University, Russia
⁴Cand. Sci. (Med.), Head of the Scientific, Department of Emergency Cardiology for Patients with Myocardial Infarction, N.V. Sklifosovsky, Research Institute for Emergency Medicine, Russia
⁵Head of the Department of X-ray, Surgical Methods for Diagnosis and Treatment, N.V. Sklifosovsky, Research Institute for Emergency Medicine, Russia

*Corresponding Author: Evgeniy N Ostroumov, Professor, Senior Lecturer of the Educational Center, N.V. Sklifosovsky Research Institute for Emergency Medicine, Ostroumov, Russia.

Received: March 13, 2024; Published: May 14, 2024

Abstract

With the advent of the era of multimodal studies in cardiology, new opportunities have arisen in the competent diagnosis. At the same time, the use of multimodal methods requires the adoption of collective decisions or special knowledge not only of radiologists, but also of the attending physicians. You are presented with a case where the use of such methods to explain pulmonary hypertension in a patient with coronary artery disease with normal LV EF and manifestations of heart failure, still did not allow to exclude the words "of unknown etiology" from the diagnosis.

 Keywords: Pulmonary Hypertension; Heart Failure; Normal LV Ejection Fraction; Myocardial Viability; Nitroglycerin Test

References

1. JOHN HM., et al. “Improvement in Left Ventricular Wall Motion Following Nitroglycerin”. Circulation 51 (1975).
2. “ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary”. 108.11 (2003): 1404-1418.
3. Gianni Bisi., et al. “Sublingual Isosorbide Dinitrate to Improve Technetium-.99m-Teboroxime Perfusion Defect Reversibility”. The Journal of Nuclear Medicine 35 (1994): 1274-1278.
4. “2013 ACCF/AHA Guideline for the Management of Heart Failure”. Circulation 128 (2013): e240-e327.
5. Gemma Cuberas-Borrós., et al. “Gated-SPECT myocardial perfusion imaging as a complementary technique to magnetic resonance imaging in chronic myocardial infarction patients”. Revista Española de Cardiología 9 (2013): 721-727.
6. Ilias Mylonas and Rob S B Beanlands. “Radionuclide Imaging of Viable Myocardium: Is it Underutilized?” Current Cardiovascular Imaging Reports 4 (2011): 251-261.
7. Yang MF., et al. “Nitrate-augmented myocardial perfusion imaging for assessment of myocardial viability: recent advances”. Nuclear Medicine Communications6 (2009): 415-419.
8. Sorrentino AR., et al. “Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction”. European Journal of Nuclear Medicine and Molecular Imaging4 (2007): 558–562.

Citation

Citation: Evgeniy N Ostroumov., et al. “A Case of “Unexplained” Pulmonary Hypertension”.Acta Scientific Medical Sciences 8.5 (2024): 45-49.

Copyright

Copyright: © 2024 Evgeniy N Ostroumov., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.